Effects of Alpha Interferon Treatment on Intrinsic Anti-HIV-1 Immunity In Vivo

被引:26
作者
Abdel-Mohsen, Mohamed [1 ]
Deng, Xutao [2 ]
Liegler, Teri [1 ]
Guatelli, John C. [3 ,4 ]
Salama, Mohamed S. [5 ]
Ghanem, Hussam El-din A. [5 ]
Rauch, Andri [6 ,7 ]
Ledergerber, Bruno [8 ]
Deeks, Steven G. [1 ]
Guenthard, Huldrych F. [8 ]
Wong, Joseph K. [1 ,9 ]
Pillai, Satish K. [1 ,2 ,9 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Blood Syst Res Inst, San Francisco, CA USA
[3] Univ Calif San Diego, La Jolla, CA 92093 USA
[4] VA San Diego Healthcare Syst, San Diego, CA USA
[5] Ain Shams Univ, Fac Sci, Cairo, Egypt
[6] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland
[7] Univ Bern, Bern, Switzerland
[8] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
[9] San Francisco VA Med Ctr, Dept Med, San Francisco, CA USA
基金
美国国家卫生研究院; 瑞士国家科学基金会;
关键词
PERSISTENT LCMV INFECTION; ANTIRETROVIRAL ACTIVITY; PEGINTERFERON ALPHA-2A; RESTRICTION FACTORS; EXPRESSION PROFILE; GENE-EXPRESSION; C VIRUS; SUPPRESSION; BLOCKADE;
D O I
10.1128/JVI.02687-13
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学];
摘要
Alpha interferon (IFN-alpha) suppresses human immunodeficiency virus type 1 (HIV-1) replication in vitro by inducing cell-intrinsic retroviral restriction mechanisms. We investigated the effects of IFN-alpha/ribavirin (IFN-alpha/riba) treatment on 34 anti-HIV-1 restriction factors in vivo. Expression of several anti-HIV-1 restriction factors was significantly induced by IFN-alpha/riba in HIV/ hepatitis C virus (HCV)-coinfected individuals. Fold induction of cumulative restriction factor expression in CD4+ T cells was significantly correlated with viral load reduction during IFN-alpha/riba treatment (r(2) = 0.649; P < 0.016). Exogenous IFN-alpha induces supraphysiologic restriction factor expression associated with a pronounced decrease in HIV-1 viremia.
引用
收藏
页码:763 / 767
页数:5
相关论文
共 22 条
[1]
Expression profile of host restriction factors in HIV-1 elite controllers [J].
Abdel-Mohsen, Mohamed ;
Raposo, Rui Andre Saraiva ;
Deng, Xutao ;
Li, Manqing ;
Liegler, Teri ;
Sinclair, Elizabeth ;
Salama, Mohamed S. ;
Ghanem, Hussam El-Din A. ;
Hoh, Rebecca ;
Wong, Joseph K. ;
David, Michael ;
Nixon, Douglas F. ;
Deeks, Steven G. ;
Pillai, Satish K. .
RETROVIROLOGY, 2013, 10
[2]
Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1-Monoinfected Participants: A Phase II Clinical Trial [J].
Asmuth, David M. ;
Murphy, Robert L. ;
Rosenkranz, Susan L. ;
Lertora, Juan J. L. ;
Kottilil, Shyam ;
Cramer, Yoninah ;
Chan, Ellen S. ;
Schooley, Robert T. ;
Rinaldo, Charles R. ;
Thielman, Nathan ;
Li, Xiao-Dong ;
Wahl, Sharon M. ;
Shore, Jessica ;
Janik, Jennifer ;
Lempicki, Richard A. ;
Simpson, Yaa ;
Pollard, Richard B. .
JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (11) :1686-1696
[3]
Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration [J].
Azzoni, Livio ;
Foulkes, Andrea S. ;
Papasavvas, Emmanouil ;
Mexas, Angela M. ;
Lynn, Kenneth M. ;
Mounzer, Karam ;
Tebas, Pablo ;
Jacobson, Jeffrey M. ;
Frank, Ian ;
Busch, Michael P. ;
Deeks, Steven G. ;
Carrington, Mary ;
O'Doherty, Una ;
Kostman, Jay ;
Montaner, Luis J. .
JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (02) :213-222
[4]
Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways [J].
Garcia-Arriaza, Juan ;
Arnaez, Pilar ;
Gomez, Carmen E. ;
Sorzano, Carlos Oscar S. ;
Esteban, Mariano .
PLOS ONE, 2013, 8 (06)
[5]
Interferon-α Is the Primary Plasma Type-I IFN in HIV-1 Infection and Correlates with Immune Activation and Disease Markers [J].
Hardy, Gareth A. D. ;
Sieg, Scott ;
Rodriguez, Benigno ;
Anthony, Donald ;
Asaad, Robert ;
Jiang, Wei ;
Mudd, Joseph ;
Schacker, Timothy ;
Funderburg, Nicholas T. ;
Pilch-Cooper, Heather A. ;
Debernardo, Robert ;
Rabin, Ronald L. ;
Lederman, Michael M. ;
Harding, Clifford V. .
PLOS ONE, 2013, 8 (02)
[6]
Host Gene Expression Changes Correlating With Anti-HIV-1 Effects in Human Subjects After Treatment With Peginterferon Alfa-2a [J].
Hubbard, Jonathan J. ;
Greenwell-Wild, Teresa ;
Barrett, Lisa ;
Yang, Jun ;
Lempicki, Richard A. ;
Wahl, Sharon M. ;
Asmuth, David M. ;
Murphy, Robert L. ;
Pollard, Richard B. ;
Kottilil, Shyam .
JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (09) :1443-1447
[7]
VIRUS INTERFERENCE .1. THE INTERFERON [J].
ISAACS, A ;
LINDENMANN, J .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1957, 147 (927) :258-267
[8]
Interferon-Alpha Administration Enhances CD8+T Cell Activation in HIV Infection [J].
Manion, Maura ;
Rodriguez, Benigno ;
Medvik, Kathleen ;
Hardy, Gareth ;
Harding, Clifford V. ;
Schooley, Robert T. ;
Pollard, Richard ;
Asmuth, David ;
Murphy, Robert ;
Barker, Edward ;
Brady, Kirsten E. ;
Landay, Alan ;
Funderburg, Nick ;
Sieg, Scott F. ;
Lederman, Michael M. .
PLOS ONE, 2012, 7 (01)
[9]
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus [J].
Marucco, D. Aguilar ;
Veronese, L. ;
de Requena, D. Gonzalez ;
Bonora, S. ;
Calcagno, A. ;
Cavecchia, I. ;
Sinicco, A. ;
De Rosa, F. G. ;
Cariti, G. ;
Di Perri, G. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (03) :565-568
[10]
Human Immunodeficiency Virus, Restriction Factors, and Interferon [J].
Neil, Stuart ;
Bieniasz, Paul .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2009, 29 (09) :569-580